INTERCEPT platelet components
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INTERCEPT platelet components, covering 2018-10-30 to 2022-10-27. Get the full timeline:
Most recent: Clinical Trial Update: In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days [Phase 2]